Search results
Should You Buy Ozempic Maker Novo Nordisk Before Its Stock Split?
Motley Fool· 8 months agoDiabetes drug Ozempic, along with its sibling product Wegovy, has provided a massive tailwind for...
Monroe County drug maker Catalent to cut 130 jobs. What we know
The Herald-Times via Yahoo News· 2 months agoDrug maker Catalent is cutting 130 jobs in Bloomington. The company said in an emailed statement the...
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Motley Fool via Yahoo Finance· 2 weeks agoThe pharmaceutical industry is currently experiencing something of a renaissance thanks to the rise...
AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth
Investor's Business Daily· 2 years agoAstraZeneca leaned on cancer and diabetes drugs in the third-quarter, leading to double-digit sales...
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: OrsoBio, a biotechnology startup developing drugs for obesity, said Tuesday it raised...
After Wegovy's Approval to Treat Heart Disease, Novo Nordisk Continues to Make Moves
Motley Fool via Yahoo Finance· 1 month agoDiabetes and obesity care are two engines fueling the pharmaceutical industry right now. Novo...
If I Could Only Buy 1 Stock Right Now, This Would Be It
Motley Fool· 6 months agoMedtronic (NYSE: MDT) is a stock I bought and have added to several times. I'm not a...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune via Yahoo Finance· 2 weeks agoGood morning. At least one sector has shrugged off the current economic uncertainty, and now the...
Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn
InvestorPlace via Yahoo Finance· 7 months agoIn recent months, diabetes stocks have retreated sharply, partly due to the increased popularity of...
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Investor's Business Daily· 2 years agoMerck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris...